Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Distribution

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Revenue projections:

Revenue projections for MCK
Revenue projections for MCK

MCK's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 0.876000
forwardPE 14.665699
debtToEquity 0.000000
earningsGrowth 0.380000
revenueGrowth 0.114000
grossMargins 0.034530
operatingMargins 0.015450
trailingEps 38.350000
forwardEps 50.191270

McKesson Corporation's Forward PE is in a favorable range, meaning its stock price compares well with its earnings and isn't overpriced. This leaves room for growth, making it a compelling opportunity for investors looking to benefit from potential future gains.
With positive earnings and revenue growth, McKesson Corporation is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
MCK's forward EPS surpasses its trailing EPS, indicating that the company is expected to be more profitable in the current financial year. This reflects growing confidence in MCK's earnings potential, suggesting stronger financial performance compared to the previous year.

Price projections:

Price projections for MCK
Price projections for MCK

MCK's present price relative to projections does not indicate any obvious risks or opportunities. This balanced situation suggests a period of stability, where investors may find it prudent to maintain their current strategies until more information becomes available.

Insider Transactions:

Insider Transactions for MCK
Insider Transactions for MCK


20 MCK shares were sold in recent transactions, with market price at 774.7000061035156.The period under consideration saw no sell transactions.The trend of more buys compared to sells around MCK's current price levels may signal investor optimism. This behavior suggests that the market is expecting a favorable outcome for the stock, leading to increased buying activity.

Recommendation changes over time:

Recommendations trend for MCK
Recommendations trend for MCK


Analysts have shown a buy bias for MCK, marking it as a favorable investment option. This could inspire investors to see MCK as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.